U.S. health regulators could approve a third Covid-19 shot for adults beginning at least six months after full vaccination, instead of the previously announced eight-month gap, the Wall Street Journal reported on Aug. 25.
The first human case of a new strain of avian flu was diagnosed in China in late May. Chinese health authorities say there is a low risk of contagion. After China notoriously underreported COVID-19 mortality, can this new assurance be trusted?
A report on the origins of Covid-19 by a U.S. government national laboratory concluded that the hypothesis of a virus leak from a Chinese lab in Wuhan is plausible and deserves further investigation, the Wall Street Journal said on June 7, citing people familiar with the classified document.
Thermo Fisher Scientific Inc. is acquiring contract researcher PPD Inc. for $17.4 billion as the medical device maker adds more muscle to the company’s pharmaceutical services business.
The United States identified three online publications directed by Russia’s intelligence services that it says are seeking to undermine Covid-19 vaccines produced by Pfizer and Moderna, a State Department spokeswoman said.
U.S. scientists are skeptical of a one-shot regimen for Pfizer Inc. and Moderna Inc. Covid-19 vaccines, saying there is not enough evidence that a single dose provides long-term protection, the Wall Street Journal reported.
Chinese authorities refused to provide World Health Organization investigators with raw, personalized data on early Covid-19 cases that could help them determine how and when the coronavirus first began to spread in China, the Wall Street Journal reported, citing WHO investigators.
A Covid-19 vaccine being developed by CSL Ltd. and the University of Queensland was scrapped after numerous vaccine recipients reported receiving false positives on certain HIV tests, according to the Wall Street Journal.
The U.S. Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee voted 17-4 to recommend Pfizer and BioNTech’s Covid-19 vaccine for Emergency Use Authorization (EUA) for individuals ages 16 years and older.
The Wall Street Journal reported that at least six pharmaceutical companies working on vaccines and therapeutics for Covid-19 were targeted by North Korean hackers
